Tvrzeni o bezpecnosti nebo snasenlivosti u cloveka z nich nelze odvodit
Goed om te weten
It is estimated one in 100 people taking semaglutide will experience pancreatitis according to safety information distributed with the drug
Nausea, vomiting, diarrhea, and constipation are the most common adverse events, are generally mild to moderate, are dose-related, and cluster during the dose-escalation phase
Richards J, Bang N, Ratliff EL, et al
WeightWatchers app includes GLP-1-specific features like injection logging (tracking medication, dose, site, and side effects), protein and fibre tracking, on-demand strength training videos, and access to over 12,000 recipes